Navigation Links
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Date:5/1/2012

two clinical experts spoke to members of the American Radium Society at a satellite symposium that took place during the Society's 94th Annual Meeting in Las Vegas.

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 6,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.  Varian's medical devices are indicated to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body when radiation treatment is indicated. While clinical studies such as those highlighted here may support the effectiveness of Varian's technology when used for radiotherapy or radiosurgery, individual results may vary. There are no guarantees of outcome, and Varian's regulatory clearances do not incorporate survival claims.

[1]  Lagerwaard F.J. et al., Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53.

[2] Chamogeorgakis TP et al. Thoracoscore predicts midterm mortality in patients undergoing thoracic surgery. J Thorac Cardiovasc Surg. 2007 Feb;133(2):325-32.

FOR INF
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
2. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
3. Retrospective Analysis Explores LYSTEDA®s Ability to Reduce Sleep Interruptions in Women With Cyclic Heavy Menstrual Bleeding
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... CHARLOTTESVILLE, Va. , May 28 The Focused Ultrasound Surgery ... the 2nd International Symposium on MR-guided Focused Ultrasound and can be accessed ... , , ... near Dulles International Airport, Washington, DC , the symposium ...
... ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD, PUMDU and PUMDW), ... will be attending the American Urological Association (AUA) 2010 Annual ... – June 1 . At the conference, the ... to educate urologists about the concept and potential of elasticity ...
Cached Medicine Technology:Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 2Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 3ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010 2
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... - Avoid Select Vitamins, Try Acupuncture, NORTHBROOK, ... American College of Chest Physicians (ACCP) recommend,against the ... general,screening of lung cancer. Published as a supplement ... of the ACCP, the guidelines cite there,is little ...
... Ohio, Sept. 10 AtriCure, Inc.,(Nasdaq: ATRC ... and selling innovative cardiac surgical devices, announced,today that ... implanted during an open-heart surgical procedure performed by,Professor ... University of Zurich,in Switzerland with the support of ...
... think they have a vaginal yeast infection are wrong ... treating their problem, says a Saint Louis University researcher ... isnt a yeast infection, said Susan Hoffstetter, Ph.D., assistant ... Louis University School of Medicine and a SLUCare womens ...
... Sept. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ... officer, will provide an update on,the progress of Sangamo,s ... business strategy at 1:30 pm (PT) on Monday,September 17, ... San Francisco. The presentation will be webcast live ...
... A vascular surgery technique pioneered at UT Southwestern ... thigh to repair the aorta does not create blood-flow ... patients, researchers report. , Vascular disease is a major ... of the aorta. Inserting synthetic grafts to repair damaged ...
... could fight cancer, heart disease, researchers say , , MONDAY, Sept. ... life, a new European study suggests. , "The intake ... from any cause of death," said lead researcher Dr. Philippe ... Lyon, France. , The new finding, published in the Sept. ...
Cached Medicine News:Health News:New Lung Cancer Guidelines Oppose General CT Screening 2Health News:New Lung Cancer Guidelines Oppose General CT Screening 3Health News:New Lung Cancer Guidelines Oppose General CT Screening 4Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 2Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 3Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 4Health News:Common misdiagnosis: most women believe they have a yeast infection when they don't 2Health News:Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference 2Health News:Natural aorta grafts have few side effects for infection-prone patients 2Health News:Vitamin D Supplements May Lengthen Life 2
... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
... Bridge assembly allows internal or ... cooling coil allows rapid cool-down ... within approximately 10 C of ... is only 5.7 inches wideideal ...
Inquire...
Medicine Products: